Concert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare Conference
26 Mayo 2020 - 6:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that Roger Tung, Ph.D., President and Chief Executive Officer, will
be participating in a fireside chat at the Jefferies Virtual Global
Healthcare Conference on June 2, 2020, at 2:00 p.m. ET.
A live webcast of the event may be accessed in the Investors
section of the Company’s website at www.concertpharma.com. A replay
of the webcast will be available on Concert’s website for two weeks
following the presentation.
About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company focused on applying its DCE Platform® (deuterated chemical
entity platform) to create novel medicines designed to treat
serious diseases and address unmet patient needs. The Company’s
approach starts with previously studied compounds, including
approved drugs, in which deuterium substitution has the potential
to enhance clinical safety, tolerability or efficacy. Concert’s
pipeline of innovative medicines targets autoimmune diseases and
central nervous systems (CNS) disorders. For more information
please visit www.concertpharma.com or follow us on Twitter at
@ConcertPharma or on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200526005032/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about Concert Pharmaceuticals Inc (NASDAQ): 0 recent articles
Más de Concert Pharmaceuticals, Inc. Artículos de Noticias